home / stock / ecor / ecor quote
Last: | $6.2394 |
---|---|
Change Percent: | -3.51% |
Open: | $5.9 |
Close: | $6.2394 |
High: | $6.35 |
Low: | $5.8 |
Volume: | 5,649 |
Last Trade Date Time: | 04/30/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.2394 | $5.9 | $6.2394 | $6.35 | $5.8 | 5,649 | 04-30-2024 |
$5.7 | $5.75 | $5.7 | $6.0927 | $5.7 | 5,033 | 04-29-2024 |
$5.76 | $5.65 | $5.76 | $6.0171 | $5.6135 | 17,008 | 04-26-2024 |
$5.65 | $5.58 | $5.65 | $5.8323 | $5.43 | 12,585 | 04-25-2024 |
$5.58 | $5.75 | $5.58 | $5.816 | $5.58 | 4,888 | 04-24-2024 |
$5.66 | $5.62 | $5.66 | $6.11 | $5.62 | 7,275 | 04-23-2024 |
$5.62 | $5.63 | $5.62 | $5.98 | $5.62 | 6,665 | 04-22-2024 |
$5.65 | $5.76 | $5.65 | $6.3399 | $5.65 | 7,408 | 04-19-2024 |
$5.64 | $5.92 | $5.64 | $5.92 | $5.63 | 5,742 | 04-18-2024 |
$5.5852 | $5.56 | $5.5852 | $5.74 | $5.32 | 13,949 | 04-17-2024 |
$5.51 | $5.67 | $5.51 | $5.86 | $5.51 | 12,620 | 04-16-2024 |
$5.67 | $5.52 | $5.67 | $5.8599 | $5.52 | 5,248 | 04-15-2024 |
$5.74 | $5.85 | $5.74 | $5.92 | $5.71 | 3,294 | 04-12-2024 |
$5.99 | $5.8 | $5.99 | $5.99 | $5.48 | 12,817 | 04-11-2024 |
$5.83 | $5.97 | $5.83 | $6.14 | $5.81 | 5,563 | 04-10-2024 |
$6.01 | $6 | $6.01 | $6.26 | $5.8501 | 10,432 | 04-09-2024 |
$5.85 | $6.06 | $5.85 | $6.2199 | $5.775 | 15,252 | 04-08-2024 |
$6.02 | $6.205 | $6.02 | $6.23 | $6.02 | 7,849 | 04-05-2024 |
$6.35 | $6.27 | $6.35 | $6.5245 | $6.1451 | 6,007 | 04-04-2024 |
$6.36 | $6 | $6.36 | $6.77 | $6 | 23,394 | 04-03-2024 |
News, Short Squeeze, Breakout and More Instantly...
ROCKAWAY, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of its most recent Truvaga Plus consumer study conducted earlier this year. Based on a 30...
2024-04-21 00:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile app-enabled product for general wellness, Truvaga Plus, which will be available on www...